ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

ClinicalTrials.gov ID: NCT06834347

Public ClinicalTrials.gov record NCT06834347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Study identification

NCT ID
NCT06834347
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

  • Itepekimab (SAR440340) Drug
  • Mometasone furoate nasal spray (MFNS) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 11, 2025
Primary completion
Jan 7, 2027
Completion
Dec 12, 2027
Last update posted
Apr 27, 2026

2025 – 2027

United States locations

U.S. sites
21
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037 Arcadia California 91006 Recruiting
Sensa Health- Site Number : 8400038 Los Angeles California 90006 Recruiting
Newport Native MD- Site Number : 8400031 Newport Beach California 92663 Recruiting
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400064 Roseville California 95661 Recruiting
Breathe Clear Institute of Sinus and Allergy Relief- Site Number : 8400040 Torrance California 90503 Recruiting
Orso Health - Torrance - Hawthorne Boulevard- Site Number : 8400035 Torrance California 90505 Recruiting
Advanced Research Associates (ARA) Professionals- Site Number : 8400011 Miami Florida 33176 Recruiting
Paradisus Med Research - Miami- Site Number : 8400009 Miami Florida 33185 Recruiting
Orlando ENT Associates - Orlando- Site Number : 8400008 Orlando Florida 32807 Recruiting
Emory University School of Medicine- Grady Campus- Site Number : 8400047 Atlanta Georgia 30303 Recruiting
Treasure Valley Medical Research- Site Number : 8400063 Boise Idaho 83706 Recruiting
University of Chicago Medical Center- Site Number : 8400018 Chicago Illinois 60637 Recruiting
Deaconess Clinic Allergy East- Site Number : 8400056 Evansville Indiana 47715 Recruiting
SSM Health Saint Louis University Hospital- Site Number : 8400005 St Louis Missouri 63104 Recruiting
Northwell Health Physician Partners Rheumatology at Great Neck- Site Number : 8400028 Great Neck New York 11021 Recruiting
Essential Medical Research- Site Number : 8400066 Tulsa Oklahoma 74137 Recruiting
TEN20 Clinical Research - Dallas- Site Number : 8400015 Dallas Texas 75244 Recruiting
Houston Methodist Hospital- Site Number : 8400054 Houston Texas 77030 Recruiting
ENT Associates of Texas - McKinne- Site Number : 8400062 McKinney Texas 75070 Recruiting
Alamo ENT Associates- Site Number : 8400065 San Antonio Texas 78258 Recruiting
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400046 Norfolk Virginia 23510 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06834347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06834347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →